320 related articles for article (PubMed ID: 37794101)
41. Molecular monitoring of Tunisian patients with chronic myeloid leukemia.
Menif S; Ben Youssef Y; Bellaaj H; Ben Lakhal R; Laatiri A
Tunis Med; 2017 Dec; 95(12):229-231. PubMed ID: 29878287
[TBL] [Abstract][Full Text] [Related]
42. Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression data.
Yeung KY; Gooley TA; Zhang A; Raftery AE; Radich JP; Oehler VG
Bioinformatics; 2012 Mar; 28(6):823-30. PubMed ID: 22296787
[TBL] [Abstract][Full Text] [Related]
43. Translating trial-based molecular monitoring into clinical practice: importance of international standards and practical considerations for community practitioners.
Akard LP; Wang YL
Clin Lymphoma Myeloma Leuk; 2011 Oct; 11(5):385-95. PubMed ID: 21723805
[TBL] [Abstract][Full Text] [Related]
44. [Evolution of BCR-ABL1 Testing for Chronic Myeloid Leukemia Under Tyrosine Kinase Inhibitor Treatment].
Miyachi H
Rinsho Byori; 2017 Jan; 65(1):52-58. PubMed ID: 30695512
[TBL] [Abstract][Full Text] [Related]
45. Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients.
Koren-Michowitz M; Shimoni A; Daraio F; Crasto F; Lorenzatti R; Volchek Y; Amariglio N; Gottardi E; Saglio G; Nagler A
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1852-5. PubMed ID: 26151304
[TBL] [Abstract][Full Text] [Related]
46. Adherence to Monitoring Tests in Patients With Chronic Myeloid Leukemia in Lebanon.
Massoud M; Nasr F; Sakr R; Hawi J; Kerbage F; Chahine G
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S101-4. PubMed ID: 27220473
[TBL] [Abstract][Full Text] [Related]
47. Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
Nair AP; Barnett MJ; Broady RC; Hogge DE; Song KW; Toze CL; Nantel SH; Power MM; Sutherland HJ; Nevill TJ; Abou Mourad Y; Narayanan S; Gerrie AS; Forrest DL
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1437-44. PubMed ID: 25865648
[TBL] [Abstract][Full Text] [Related]
48. Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression.
Wang WJ; Zheng CF; Liu Z; Tan YH; Chen XH; Zhao BL; Li GX; Xu ZF; Ren FG; Zhang YF; Chang JM; Wang HW
Eur J Haematol; 2018 Sep; 101(3):291-296. PubMed ID: 29691899
[TBL] [Abstract][Full Text] [Related]
49. MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation.
Giles FJ; Cortes J; Jones D; Bergstrom D; Kantarjian H; Freedman SJ
Blood; 2007 Jan; 109(2):500-2. PubMed ID: 16990603
[TBL] [Abstract][Full Text] [Related]
50. [Genetic diagnosis of chronic myeloid leukemia].
Kato C; Naoe T
Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
[TBL] [Abstract][Full Text] [Related]
51. Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.
Jabbour E; Cortes J; Kantarjian HM; Giralt S; Jones D; Jones R; Giles F; Andersson BS; Champlin R; de Lima M
Blood; 2006 Aug; 108(4):1421-3. PubMed ID: 16601247
[TBL] [Abstract][Full Text] [Related]
52. [Molecular basis of chronic myelogenous leukemia and significance of diagnostic methods based on BCR-ABL gene amplification].
Sacha T; Dulak J; Skotnicki AB; Dembińska-Kiec A
Przegl Lek; 1999; 56 Suppl 1():57-61. PubMed ID: 10494184
[TBL] [Abstract][Full Text] [Related]
53. The detection and significance of minimal residual disease in chronic myeloid leukemia.
Radich JP
Medicina (B Aires); 2000; 60 Suppl 2():66-70. PubMed ID: 11188935
[TBL] [Abstract][Full Text] [Related]
54. Novel treatment strategies for chronic myeloid leukemia.
Fausel CA
Am J Health Syst Pharm; 2006 Dec; 63(23 Suppl 8):S15-20; quiz S21-2. PubMed ID: 17106016
[TBL] [Abstract][Full Text] [Related]
55. Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia.
Lavrov AV; Ustaeva OA; Adilgereeva EP; Smirnikhina SA; Chelysheva EY; Shukhov OA; Shatokhin YV; Mordanov SV; Turkina AG; Kutsev SI
PLoS One; 2017; 12(9):e0182901. PubMed ID: 28902850
[TBL] [Abstract][Full Text] [Related]
56. The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia.
Crisan AM; Coriu D; Arion C; Colita A; Jardan C
J Med Life; 2015; 8(4):502-8. PubMed ID: 26664479
[TBL] [Abstract][Full Text] [Related]
57. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation.
Lin F; van Rhee F; Goldman JM; Cross NC
Blood; 1996 May; 87(10):4473-8. PubMed ID: 8639810
[TBL] [Abstract][Full Text] [Related]
58. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
Saussele S; Richter J; Guilhot J; Gruber FX; Hjorth-Hansen H; Almeida A; Janssen JJWM; Mayer J; Koskenvesa P; Panayiotidis P; Olsson-Strömberg U; Martinez-Lopez J; Rousselot P; Vestergaard H; Ehrencrona H; Kairisto V; Machová Poláková K; Müller MC; Mustjoki S; Berger MG; Fabarius A; Hofmann WK; Hochhaus A; Pfirrmann M; Mahon FX;
Lancet Oncol; 2018 Jun; 19(6):747-757. PubMed ID: 29735299
[TBL] [Abstract][Full Text] [Related]
59. [Importance of quantitative evaluation of BCR-ABL transcripts using real-time PCR for effective treatment of chronic myeloid leukemia].
Beránek M; Voglová J; Sýkorová A; Belada D; Bláha M
Cas Lek Cesk; 2006; 145(1):25-9; discussion 29-30. PubMed ID: 16468238
[TBL] [Abstract][Full Text] [Related]
60. Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Alyea EP; Soiffer RJ; Roy DC; Ritz J
Blood; 1994 Oct; 84(7):2109-14. PubMed ID: 7919323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
